Occam Places Alex Dickinson as Board Member of Gencove
Gencove, a rapidly-growing private venture democratizing genome sequencing by making genomic information more accessible and interpretable through the development of molecular and computational tools, has appointed Alex Dickinson as the first independent Board member.
Dickinson brings deep commercial and technical experience in the genomics and molecular diagnostics industry, wisdom that will serve Gencove’s founding CEO well as he seeks to execute on the platform’s substantial potential in disrupting the sequencing market at scale.
Gencove, which was spun out of the New York Genome Center, recently raised a Series A round of $10M led by Lewis & Clark AgriFood with participation from Spero Ventures, Techammer, Third Kind Venture Capital, and Version One Ventures.
Recent Placements
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.